Full Text View
Tabular View
No Study Results Posted
Related Studies
EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)
This study has been completed.
Study NCT00089895   Information provided by Schering-Plough
First Received: August 17, 2004   Last Updated: December 17, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Myocardial Ischemia
Acute Coronary Syndrome
Additional conditions recognized in this trial
Ischemia
Syndrome
More general conditions related to this trial
Cardiovascular Diseases
Disease
Heart Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Eptifibatide (Integrilin)
Placebo
Additional drug interventions recognized in this trial
Eptifibatide
PS-K
More general drug interventions related to this trial
Adjuvants, Immunologic
Anti-Infective Agents
Antibiotics, Antineoplastic
Antineoplastic Agents
Antiviral Agents
Hematologic Agents
Immunologic Factors
Interferon Inducers
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Protective Agents
Radiation-Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Schering-Plough
Duke University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services